• A Montagnani, F Pieralli, P Gnerre, F Pomero, M Campanini, F Dentali, A Fontanella, D Manfellotto, and FADOI CoViD-19 Observatory Group.
• Internal Medicine, Hospital of Pitigliano, Grosseto, Italy.
• Diabetes Res. Clin. Pract. 2020 Sep 1; 167: 108335.

AbstractAvailable data suggest that the issue of CoViD-19 is particularly critical in patients with diabetes. In Italy, Internal Medicine (IM) wards have played a pivotal role in contrasting the spread of SARS-Cov2. During this pandemic, FADOI submitted a brief questionnaire to a group of its members acting as Head of IM units. Considering 38 units, 58% of beds dedicated to CoViD patients in CoViD Hospitals were in charge of IM, and globally cared for 6650 patients during a six-week period. Of these patients, 1264 (19%) had diabetes. Mortality rate in CoViD patients with or without diabetes were 20.5% and 14%, respectively (p < 0.001). Our survey seems to confirm that diabetes is a major comorbidity of CoViD-19, but it does not support an increased incidence of CoViD-19 infection in people with diabetes, if compared with the figures of patients with diabetes and hospitalized before the outbreak. On the other side, patients with diabetes appeared at a significantly increased risk of worse outcome. This finding underlines the importance of paying special attention to this patient population and its management.Copyright © 2020. Published by Elsevier B.V.

26 keywords...

hide…